Skip to main content
The BMJ logoLink to The BMJ
. 1992 Apr 25;304(6834):1103–1105. doi: 10.1136/bmj.304.6834.1103

Gene regulation.

D S Latchman 1
PMCID: PMC1881938  PMID: 1375124

Full text

PDF
1103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bishop J. M. The molecular genetics of cancer. Science. 1987 Jan 16;235(4786):305–311. doi: 10.1126/science.3541204. [DOI] [PubMed] [Google Scholar]
  2. Crossley M., Brownlee G. G. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature. 1990 May 31;345(6274):444–446. doi: 10.1038/345444a0. [DOI] [PubMed] [Google Scholar]
  3. Grandchamp B., Picat C., Mignotte V., Wilson J. H., Te Velde K., Sandkuyl L., Roméo P. H., Goossens M., Nordmann Y. Tissue-specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci U S A. 1989 Jan;86(2):661–664. doi: 10.1073/pnas.86.2.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Latchman D. S. Cell-type-specific splicing factors and the regulation of alternative RNA splicing. New Biol. 1990 Apr;2(4):297–303. [PubMed] [Google Scholar]
  5. Latchman D. S. Eukaryotic transcription factors. Biochem J. 1990 Sep 1;270(2):281–289. doi: 10.1042/bj2700281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lenardo M. J., Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989 Jul 28;58(2):227–229. doi: 10.1016/0092-8674(89)90833-7. [DOI] [PubMed] [Google Scholar]
  7. Nevins J. R. The pathway of eukaryotic mRNA formation. Annu Rev Biochem. 1983;52:441–466. doi: 10.1146/annurev.bi.52.070183.002301. [DOI] [PubMed] [Google Scholar]
  8. Olson E. N. MyoD family: a paradigm for development? Genes Dev. 1990 Sep;4(9):1454–1461. doi: 10.1101/gad.4.9.1454. [DOI] [PubMed] [Google Scholar]
  9. Reith W., Satola S., Sanchez C. H., Amaldi I., Lisowska-Grospierre B., Griscelli C., Hadam M. R., Mach B. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell. 1988 Jun 17;53(6):897–906. doi: 10.1016/s0092-8674(88)90389-3. [DOI] [PubMed] [Google Scholar]
  10. Sharp P. A. Splicing of messenger RNA precursors. Science. 1987 Feb 13;235(4790):766–771. doi: 10.1126/science.3544217. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES